ZHANG Jianbo,ZHU Naping,CHEN Jie, et al. The effect of resveratrol on the expression of brain-derived neurotrophic factor in rats with irritable bowel syndrome[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(3): 178-184.
Abstract:Objective: To investigate the effect of resveratrol on depression- and anxiety-like behaviors, intestinal motility and visceral sensitivity in rats with irritable bowel syndrome. Methods: Forty-two SD rats were randomly divided into normal control group, chronic-acute combined stress (CACS) group, resveratrol group with different doses (10, 20 and 40 mg/kg), fluoxetine group and diazepam group. Twenty-two day CACS was used to established CACS model. The depression- and anxiety-like behaviors were evaluated by forced swimming test and marble-burying task. Intestinal motility and visceral sensitivity were measured by intestinal motility test and AWR test. The levels of brain-derived neurotrophic factor (BDNF) in hippocampus, frontal cortex, ileum and colon were measured by Western blot. Results: Compared with the normal group, the duration of immobility time of forced swimming and the number of marble buried was significantly increased (P<0.01 and P<0.01, respectively); the number of fecal output (P<0.01) in the intestinal motility test and the abdominal withdrawal reflex (AWR) score were also increased in CACS group (20 mmHg: P<0.05; 40 mmHg: P<0.05; 60 mmHg: P<0.01; 80 mmHg: P<0.01). The expression of BDNF in hippocampus (P<0.01) and the frontal cortex (P<0.01) were decreased, while the expression of BDNF in colon (P<0.01) and ileum (P<0.05) were increased in the CACS group, as compared with the normal control group. After 22-day treatment with resveratrol, the above data have been improved. Conclusion: Resveratrol ameliorated the behavior of IBS rats, which is likely to be related to the regulation of BDNF expression in the brain and gut.
[1] DROSSMAN D A, MORRIS C B, SCHNECK S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit[J]. J Clin Gastroenterol, 2009, 43 (6): 541-550.
[2] KIBUNE N C, GARCIA M C, SILVA L S L, et al. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities[J]. Rev Esp Enferm Dig, 2016, 108(2): 59-64.
[3] BENGTSON M B, AAMODT G, VATN M H, et al. Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth[J]. BMC Gastroenterol, 2015, 15: 9.
[4] JERNDAL P, RINGSTRöM G, AGERFORZ P, et al. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS[J]. Neurogastroenterol Motil, 2010, 22(6): 646-e179.
[5] 王林, 潘建春. 白藜芦醇通过调节Ca2+浓度对小鼠外周疼痛的影响及作用机制[J]. 温州医科大学学报, 2018, 48(1): 53-56, 62.
[6] XU Y, WANG Z, YOU W, et al. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system[J]. Eur Neuropsychopharmacol, 2010, 20(6): 405-413.
[7] GE J F, XU Y Y, QIN G, et al. Resveratrol ameliorates the anxiety- and depression-like behavior of subclinical hypothyroidism rat: possible involvement of the HPT axis, HPA axis, and Wnt/β-Catenin pathway[J]. Front Endocrinol (Lausanne), 2016, 7: 44.
[8] ZOU N, LV H, LI J, et al. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS)[J]. Transl Res, 2008, 152(6): 283-289.
[9] YU Y, WU S, LI J, et al. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling[J]. Metab Brain Dis, 2015, 30(1): 47-55.
[10] ZHAO Z, ZHANG L, GUO X D, et al. Rosiglitazone exerts an anti-depressive effect in unpredictable chronic mild-stress-induced depressive mice by maintaining Essential neuron autophagy and inhibiting excessive astrocytic apop-tosis[J]. Front Mol Neurosci, 2017, 10: 293.
[11] PORSOLT R D, LE P M, JALFRE M. Depression: a new animal model sensitive to antidepressant treatments[J]. Nature, 1977, 266(5604): 730-732.
[12] 许笑笑, 吴飞燕, 费宁, 等. 抑郁焦虑情绪与肠道炎症潜在交互作用探讨[J]. 温州医科大学学报, 2016, 46(5): 348-353, 358.
[13] BARONE F C, DEEGAN J F, PRICE W J, et al. Cold-restraint stress increases rat fecal pellet output and colonic transit[J]. Am J Physiol, 1990, 258(3 Pt 1): G329-337.
[14] AL-CHAER E D, KAWASAKI M, PASRICHA P J. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development[J]. Gastroenterology, 2000, 119(5): 1276-1285.
[15] FORD A C, LACY B E, TALLEY N J. Irritable Bowel Syn-drome[J]. N Engl J Med, 2017, 376(26): 2566-2578.
[16] GWEE K A, GHOSHAL U C, CHEN M. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management[J]. J Gastroenterol Hepatol, 2018, 33 (1): 99-110.
[17] CAMILLERI M, MCKINZIE S, BUSCIGLIO I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome[J]. Clin Gastroenterol Hepatol, 2008, 6(7): 772-781.
[18] ELSENBRUCH S, ROSENBERGER C, ENCK P, et al. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study[J]. Gut, 2010, 59(4): 489-495.
[19] LIU Y, ZHANG L, WANG X, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression[J]. Clin Gastroenterol Hepatol, 2016, 14(11): 1602-1611.e5.
[20] TABRIZIAN K, SHAHRAKI J, BAZZI M, et al. Neuro-protective effects of resveratrol on carbon monoxide-induced toxicity in male rats[J]. Phytother Res, 2017, 31(9): 1310-1315.
[21] 李宁宁, 方秀才. 脑-肠轴在肠易激综合征发病中的作用[J]. 胃肠病学和肝病学杂志, 2013, 22(2): 163-166.
[22] TöRNBLOM H, DROSSMAN D A. Centrally targeted pharmacotherapy for chronic abdominal pain[J]. Neurogastroenterol Motil, 2015, 27(4): 455-467.
[23] WANG G, CHEN L, PAN X, et al. The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling[J]. Oncotarget, 2016, 7(14): 17380-17392.
[24] MAQSOOD R, STONE T W. The Gut-Brain Axis, BDNF, NMDA and CNS disorders[J]. Neurochem Res, 2016, 41 (11): 2819-2835.
[25] 梁超, 徐斌. 脑源性神经营养因子在肠道中作用的研究进展[J]. 世界华人消化杂志, 2015, 23(35): 5649-5654.
[26] 周小江, 胡园, 刘屏. 脑源性神经营养因子与抑郁症的研究进展[J]. 生物化学与生物物理进展, 2011, 38(12): 1085-1090.
[27] GAWALI N B, BULANI V D, GURSAHANI M S, et al. Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway[J]. Brain Res, 2017, 1663: 66-77.
[28] MENDEZ-DAVID I, GUILLOUX J P, PAPP M, et al. S 47445 produces antidepressant- and anxiolytic-like effects through neurogenesis dependent and independent mecha-nisms[J]. Front Pharmacol, 2017, 8: 462.
[29] 赵宏宇, 陈飞雪, 曹静, 等. 脑组织海马区脑源性神经营养因子在焦虑调节内脏高敏感中的作用[J]. 山东大学学报(医学版), 2014, 52(3): 33-36.
[30] QUAN X, LUO H, FAN H, et al. Brain-derived neurotrophic factor contributes to colonic hypermotility in a chronic stress rat model[J]. Dig Dis Sci, 2015, 60(8): 2316-2326.
[31] DELAFOY L, GELOT A, ARDID D, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat[J]. Gut, 2006, 55(7): 940-945.
[32] 赵迎盼, 苏敏, 王凤云, 等. 肠安I号方对肠易激综合征内脏高敏感大鼠5-HT信号系统及海马BDNF mRNA表达的影响[J]. 中国中西医结合杂志, 2015, 35(10): 1228-1235.
[33] PARK S J, AHMAD F, PHILP A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases[J]. Cell, 2012, 148(3): 421-433.